Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aptargroup (ATR)

Aptargroup (ATR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,813,288
  • Shares Outstanding, K 65,619
  • Annual Sales, $ 3,583 M
  • Annual Income, $ 374,540 K
  • EBIT $ 793 M
  • EBITDA $ 1,057 M
  • 60-Month Beta 0.48
  • Price/Sales 2.15
  • Price/Cash Flow 12.78
  • Price/Book 2.92

Options Overview Details

View History
  • Implied Volatility 28.23% (-6.91%)
  • Historical Volatility 31.60%
  • IV Percentile 70%
  • IV Rank 40.00%
  • IV High 44.96% on 04/08/25
  • IV Low 17.08% on 02/14/25
  • Expected Move (DTE 13) 17.03 (12.68%)
  • Put/Call Vol Ratio 0.14
  • Today's Volume 107
  • Volume Avg (30-Day) 120
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 383
  • Open Int (30-Day) 939
  • Expected Range 117.28 to 151.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.17
  • Number of Estimates 1
  • High Estimate 1.17
  • Low Estimate 1.17
  • Prior Year 1.20
  • Growth Rate Est. (year over year) -2.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
117.61 +14.20%
on 01/07/26
135.99 -1.24%
on 02/06/26
+13.75 (+11.41%)
since 01/06/26
3-Month
114.00 +17.82%
on 11/10/25
135.99 -1.24%
on 02/06/26
+18.16 (+15.63%)
since 11/06/25
52-Week
103.23 +30.11%
on 10/31/25
164.28 -18.24%
on 07/24/25
-22.14 (-14.15%)
since 02/06/25

Most Recent Stories

More News
AptarGroup: Q4 Earnings Snapshot

AptarGroup: Q4 Earnings Snapshot

ATR : 134.31 (+8.33%)
Aptar Reports Fourth Quarter and Annual 2025 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended...

ATR : 134.31 (+8.33%)
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of...

ATR : 134.31 (+8.33%)
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the...

ATR : 134.31 (+8.33%)
Aptar Announces 2026 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for...

ATR : 134.31 (+8.33%)
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring

The integration aims to empower millions of users with deeper insights into migraine triggers through biometric signals.

ATR : 134.31 (+8.33%)
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced its participation at the 44 th Annual J.P....

ATR : 134.31 (+8.33%)
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

Novel treatment for PSVT developed with Milestone Pharmaceuticals

MIST : 1.7600 (+2.33%)
ATR : 134.31 (+8.33%)
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year

Ranked among the Top 100 Companies

ATR : 134.31 (+8.33%)
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare...

ATR : 134.31 (+8.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities...

See More

Key Turning Points

3rd Resistance Point 146.15
2nd Resistance Point 141.07
1st Resistance Point 137.69
Last Price 134.31
1st Support Level 129.23
2nd Support Level 124.15
3rd Support Level 120.77

See More

52-Week High 164.28
Fibonacci 61.8% 140.96
Last Price 134.31
Fibonacci 50% 133.75
Fibonacci 38.2% 126.55
52-Week Low 103.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar